[go: up one dir, main page]

RU2003114406A - VITAMIN COMPOSITION - Google Patents

VITAMIN COMPOSITION

Info

Publication number
RU2003114406A
RU2003114406A RU2003114406/15A RU2003114406A RU2003114406A RU 2003114406 A RU2003114406 A RU 2003114406A RU 2003114406/15 A RU2003114406/15 A RU 2003114406/15A RU 2003114406 A RU2003114406 A RU 2003114406A RU 2003114406 A RU2003114406 A RU 2003114406A
Authority
RU
Russia
Prior art keywords
vitamin composition
fillers
magnesium stearate
ascorbic acid
sodium ascorbate
Prior art date
Application number
RU2003114406/15A
Other languages
Russian (ru)
Other versions
RU2246936C1 (en
Inventor
Николай Андреевич Янковский
Александр Владимирович Ляшенко
Николай Николаевич Диюнов
Василий Алексеевич Юрченко
Александр Дмитриевич Петров
Леонид Васильевич Федченко
Ольга Александровна Соколюк
Андрей Вячеславович Несговоров
Олександр Олегович Спицин
Original Assignee
Открытое акционерное общество "Концерн Стирол"
Filing date
Publication date
Application filed by Открытое акционерное общество "Концерн Стирол" filed Critical Открытое акционерное общество "Концерн Стирол"
Priority to RU2003114406/15A priority Critical patent/RU2246936C1/en
Priority claimed from RU2003114406/15A external-priority patent/RU2246936C1/en
Publication of RU2003114406A publication Critical patent/RU2003114406A/en
Application granted granted Critical
Publication of RU2246936C1 publication Critical patent/RU2246936C1/en

Links

Claims (1)

Витаминная композиция, включающая действующее вещество - аскорбиновую кислоту и натрия аскорбат при их соотношении 2:3, наполнители, опудриватель - магния стеарат, отличающаяся тем, что указанные компоненты содержатся при следующем соотношении ингредиентов, мас.%:Vitamin composition, including the active substance - ascorbic acid and sodium ascorbate at a ratio of 2: 3, fillers, dusting agent - magnesium stearate, characterized in that these components are contained in the following ratio of ingredients, wt.%: Действующее вещество (аскорбиновая кислота:Active ingredient (ascorbic acid: натрия аскорбату=2:3) 58,2sodium ascorbate = 2: 3) 58.2 Наполнители 40,8Fillers 40.8 Опудриватель - магния стеарат 1,0Dusting - Magnesium Stearate 1.0
RU2003114406/15A 2003-05-19 2003-05-19 Vitamin composition RU2246936C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003114406/15A RU2246936C1 (en) 2003-05-19 2003-05-19 Vitamin composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003114406/15A RU2246936C1 (en) 2003-05-19 2003-05-19 Vitamin composition

Publications (2)

Publication Number Publication Date
RU2003114406A true RU2003114406A (en) 2004-11-20
RU2246936C1 RU2246936C1 (en) 2005-02-27

Family

ID=35286241

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003114406/15A RU2246936C1 (en) 2003-05-19 2003-05-19 Vitamin composition

Country Status (1)

Country Link
RU (1) RU2246936C1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134445A (en) * 1989-02-14 1992-07-28 Canon Kabushiki Kaisha Sample inspecting method and apparatus
RU2121360C1 (en) * 1997-09-29 1998-11-10 Гитлин Исаак Григорьевич Prophylactic and general tonic agent
DK1423109T3 (en) * 2001-09-03 2005-12-27 Dsm Ip Assets Bv Compositions comprising pectin and ascorbic acid

Similar Documents

Publication Publication Date Title
NO2025027I1 (en) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - extended.
MY141243A (en) Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
ATE380021T1 (en) CHEWING GUM IN THE FORM OF MULTI-LAYER TABLETS
EA200301275A1 (en) CAPSULES FOR INHALATION
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
DK1207756T3 (en) Use of spinosad or a formulation comprising spinosad
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
CA2367387A1 (en) Composition comprising isoquercetin and ascorbic acid in a sustained release form
HRP20050510A2 (en) Microbicide substances
WO2005065639A3 (en) Novel pharmaceutical compositions
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
WO2004039326A3 (en) Propofol with cysteine
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
ATE412404T1 (en) STABLE ORAL PHARMACEUTICAL COMPOSITIONS OF BUPRENORPHINE AND SALT THEREOF
MXPA04005033A (en) Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes.
RU2003114406A (en) VITAMIN COMPOSITION
RU2000116782A (en) FOOD BIOLOGICALLY ACTIVE ADDITIVE
RU2001100069A (en) Anthelmintic
RU2001128736A (en) A method of normalizing the reproductive function of cows
NO20041878L (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient.
RU2000113775A (en) PREPARATION AND TREATMENT OF ENDOMETRITIS
DE60221045D1 (en) NEW SUBSTANCE WITH ANTITUM EFFECT / INFLAMMATORY EFFECT